AMICUS THERAPEUTICS INC (FOLD) Stock Income Statement
NASDAQ:FOLD - Nasdaq - US03152W1099 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 543.14M | 528.29M | 399.36M | 329.20M | 305.50M | |||
| Cost Of Goods | 51.07M | 52.94M | 37.33M | 38.60M | 34.50M | |||
| Gross Profit | 492.07M | 475.35M | 362.03M | 290.60M | 271.00M | |||
| Operating Expenses | 444.28M | 441.29M | 438.11M | 496.20M | 477.40M | |||
| Research and Development | 108.87M | 109.36M | 152.38M | 276.70M | 272.00M | |||
| Selling, General, and Administrative Expenses | 327.18M | 323.38M | 275.27M | 213.00M | 192.70M | |||
| Operating Income | 47.79M | 34.06M | -76.08M | -205.50M | -206.40M | |||
| Interest Income/Expense | -43.94M | -44.19M | -43.07M | -34.10M | -32.00M | |||
| Other Income/Expense | -3.92M | -9.44M | -15.89M | 4.20M | -2.90M | |||
| Non Recurring Items | -3.14M | -9.19M | -15.07M | -6.60M | -300.00K | |||
| Income Before Taxes | -3.22M | -28.76M | -150.10M | -242.00M | -241.60M | |||
| Income Tax | 26.16M | 27.35M | 1.48M | -5.50M | 8.90M | |||
| Net Income | -29.37M | -56.11M | -151.58M | -236.60M | -250.50M | |||
| EBITDA | 56.02M | 42.61M | -68.20M | -200.16M | -200.19M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.10 | -0.18 | -0.51 | -0.82 | -0.92 | |||
| Non GAAP EPS | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 | |||
| Statistics | ||||||||
| Gross Profit Margin | 90.60% | 89.98% | 90.65% | 88.27% | 88.71% | |||
| Profit Margin | -5.41% | -10.62% | -37.96% | -71.87% | -82.00% | |||
| Operating Profit Margin | 8.80% | 6.45% | -19.05% | -62.42% | -67.56% | |||
All data in USD